This topic contains a solution. Click here to go to the answer

Author Question: Which drug would most likely be an initial treatment for a patient with Alzheimer's disease? 1. ... (Read 13 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
Which drug would most likely be an initial treatment for a patient with Alzheimer's disease?
 
  1. Levodopa (Larodopa)
  2. Haloperidol (Haldol)
  3. Benztropine mesylate (Cogentin)
  4. Donepezil hydrochloride (Aricept)

Question 2

The nurse in the emergency department frequently sees clients who have overdosed on acetaminophen (Tylenol). Which client is at highest risk for developing hemolysis?
 
  1. A Native American client
  2. A Jewish client
  3. An African American client
  4. A Caucasian client



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tuwy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

4
Rationale 1: Levodopa (Larodopa) is used for Parkinson's disease.
Rationale 2: Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.
Rationale 3: Benztropine mesylate (Cogentin) is used for Parkinson's disease.
Rationale 4: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease.
Global Rationale: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease. Levodopa (Larodopa) and benztropine mesylate (Cogentin) are used for Parkinson's disease. Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.

Answer to Question 2

3
Rationale 1: Native Americans are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 2: Jewish clients are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 3: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol).
Rationale 4: Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Global Rationale: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol). Native Americans, Jewish clients, and Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).





 

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

For a complete list of videos, visit our video library